Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Cancer research institute
Aug 23, 2023, 23:49 |
Blog
Paolo Tarantino: Interesting pan-cancer evaluation of HER2-low expression out on Annals of Oncology.
Paolo Tarantino, a Research Fellow at the Dana-Farber Cancer Institute, shared the following insights on…
Aug 23, 2023, 21:17 |
Blog
Jim Olsen: Having raised $1 million for pediatric brain tumor research, the Seattle Children's Pink Polka Dots junior guild continues to support our work.
Jim Olsen, Principal Investigator at Seattle Children's Research Institute, Professor at Fred Hutchinson Cancer Research…
Aug 23, 2023, 14:39 |
Blog
Freddy Nguyen: Michael King's and Cindy Reinhart-King's research programs have advanced treatment of cancer and other diseases.
Freddy Nguyen, a Research Fellow at the Massachusetts Institute of Technology, recently shared on LinkedIn:…
Aug 23, 2023, 14:38 |
Blog
APPLY TODAY to The Innovative Molecular Analysis Technologies (IMAT) Program - National Cancer Institute
National Cancer Institute shared on Twitter: "APPLY TODAY: The Innovative Molecular Analysis Technologies (IMAT) Program…
Aug 23, 2023, 14:35 |
Blog
Mark A. Davis: I am so proud to be have been a part of Baptist Health Cancer Care for the last two years...
Quoting Mark A. Davis, COO of Miami Cancer Institute and Baptist Health Cancer Care, on…
Aug 22, 2023, 09:55 |
Drugs
Neeraj Agarwal: Breaking news: Glad to report the news from ph3 Contact-2 trial Cabozantinib + atezolizumab significantly improved outcomes in mCRPC prostate cancer.
Neeraj Agarwal stated on Twitter: "Breaking news: Glad to report the news from ph3 Contact-2 trial…
Aug 21, 2023, 16:51 |
Insight
Ishwaria Subbiah: New guidelines on non-pharmacologic options for cancer symptom management.
Ishwaria Subbiah, the Executive Director of Cancer Care Equity and Professional Wellness at Sarah Cannon…
Aug 20, 2023, 17:41 |
Insight
Vivek Subbiah: Pan-KRAS inhibitors have broad therapeutic implications and merit clinical investigation in patients with KRAS-driven cancers.
According to Vivek Subbiah, Chief, Early-Phase Drug Development, Sarah Cannon Research Institute on LinkedIn: "Pan-KRAS…
Aug 18, 2023, 17:20 |
Blog
Don’t miss NCI’s exclusive interview with Dr. Nancy Hopkins - National Cancer Institute
National Cancer Institute shared on their Twitter page: "LISTEN: Don’t miss NCI’s exclusive interview on our…
Aug 17, 2023, 16:18 |
Blog
Monica M. Bertagnolli: Supporting President Biden's cancer moon shot goal of accelerating cancer research through improved data sharing.
Monica M. Bertagnolli shared on Twitter: ''Supporting President Biden's cancer moon shot goal of accelerating…
118
119
120
121
122
All:
2716
Posts:
1191 - 1200
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube